LACTOSE.BO

Lactose (India) Limited

HealthcareMedical - PharmaceuticalsININRPeers →Country macro →

$109.00

Jun 15, 2026

AI Brief

Market cap

$1.37B

52w range

—

P / E

—

EPS · FY 2026

$4.68

Volume

—

Revenue · FY 2026

$1.63B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Lactose (India) Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$109.00

Change

+15.12%

Period high

$127.75

Period low

$80.41

Period start

$94.682026-02-01

Through 2026-06-15

Fair value

Football field →

Weighted blend

$101.56

— vs spot

Recommendation

n/a

4 of 4 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

LACTOSE.BO

109.00+15.12%

H 136.45L 77.00MA50 100.83MA200 —Avg vol 9K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Utilities
+3.35%
Financial Services
-0.08%
Industrials
-0.11%
Healthcare
-0.72%
Energy
-0.92%
Technology
-0.94%
Consumer Defensive
-1.51%
Basic Materials
-1.60%
Consumer Cyclical
-1.74%
Communication Services
-1.77%
Real Estate
-2.20%

Top industries (issuer's industry highlighted)

Auto - Dealerships
-5.76%
Renewable Utilities
+5.32%
Trucking
-4.82%
Financial - Mortgages
-4.42%
Consulting Services
-4.17%
Oil & Gas Energy
-4.03%
REIT - Office
-3.55%
Medical - Healthcare Information Services
-3.54%
REIT - Diversified
-3.51%
Discount Stores
-3.43%
Grocery Stores
-3.42%
Integrated Freight & Logistics
-3.24%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for LACTOSE.BO.

Peers

No peer list available for LACTOSE.BO.

Total assets

$1.83B

Total debt

$624.51M

Cash & equiv

$7.4M

Operating CF

$16.68M

Free cash flow

-$88.15M

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$1.63B	$126.34M	$60.63M	$4.68	+3.71%